- Nachrichtendetail
-
03.07.2024 07:11:42 - dpa-AFX: *REGENERON: EC APPROVES DUPIXENT AS ADD-ON MAINTENANCE TREATMENT FOR ADULTS WITH COPD
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
REGENERON PHARMAC.DL-,001 | 881535 | Frankfurt | 981,600 | 09.07.24 12:01:25 | +21,400 | +2,23% | 969,400 | 984,400 | 970,200 | 960,200 |
